With offices and research and development facilities in the United States and Europe, Algenol’s operations, like its project development activities, have a global reach.
Algenol’s commercial development campus, built with assistance from Lee County, Florida, includes 90,000 square feet of world-class molecular biology, culture collection, physiology, aquaculture, analytical chemistry and engineering laboratories in Fort Myers, Florida. The campus includes our Process Development Unit (PDU), which itself consists of a 9,500-square foot aquaculture laboratory, two large inoculation greenhouses and 3 acres of outdoor controlled testing area for initial deployment and optimization activities.
In October 2011, we broke ground on the Department of Energy sponsored pilot-scale Integrated Biorefinery in Fort Myers on 36 acres adjacent to the PDU. The Integrated Biorefinery has the capacity to produce up to 10,000 gallons of ethanol per year and will contain thousands of photobioreactors on up to 2 “wetted” acres, along with supporting processes and infrastructure collectively providing a microcosm of a commercial facility. Upon completion of the Integrated Biorefinery in 2013, Algenol established perhaps the most sophisticated algae facility in the world where an algae strain can go from lab-scale development to commercial-scale production on one site.
In 2014 Algenol will continue to operate the Integrated Biorefinery to demonstrate commercial viability of the technology by showcasing all of the upstream and downstream systems necessary to produce ethanol, gasoline, jet fuel and diesel. Additionally in 2014, Algenol has initiated plans to establish manufacturing facilities in Lee County that will support commercial projects around the world.
With our subsidiary, Algenol Biofuels Germany GmbH (formerly, Cyano Biofuels GmbH), we also have an international team of 50 highly qualified researchers working in a molecular biology laboratory in Berlin, Germany. Established in 2007, the operation was primarily focused on algal biology research and development and, in October 2010, became a wholly owned subsidiary of Algenol. Our operation in Berlin is recognized within the European scientific community as an outstanding partner in various collaborative projects.
Algenol Biofuels Switzerland GmbH, another wholly owned subsidiary, manages our international operations. It is located in Zug, Switzerland and oversees all non-US research, development and finance activities, as well as international licensing and project development.